A prediction model for pathological complete response after neoadjuvant chemotherapy of HER2-negative breast cancer patients

被引：0
|
作者：
Haeberle, L. [1 ]
Erber, R. [2 ]
Gass, P. [1 ]
Hein, A. [1 ]
Jud, S. M. [1 ]
Langemann, H. [1 ]
Rauh, C. [1 ]
Hack, C. C. [1 ]
Schulz-Wendtland, R. [3 ]
Hartmann, A. [2 ]
Beckmann, M. W. [1 ]
Lux, M. P. [1 ]
Fasching, P. A. [1 ]
机构：
[1] Erlangen Univ Hosp, Dept Gynecol & Obstet, Erlangen, Germany
[2] Erlangen Univ Hosp, Inst Pathol, Erlangen, Germany
[3] Erlangen Univ Hosp, Inst Radiol, Erlangen, Germany
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
226P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markers
    Haeberle, Lothar
    Erber, Ramona
    Gass, Paul
    Hein, Alexander
    Niklos, Melitta
    Volz, Bernhard
    Hack, Carolin C.
    Schulz-Wendtland, Ruediger
    Huebner, Hanna
    Goossens, Chloe
    Christgen, Matthias
    Doerk, Thilo
    Park-Simon, Tjoung-Won
    Schneeweiss, Andreas
    Untch, Michael
    Nekljudova, Valentina
    Loibl, Sibylle
    Hartmann, Arndt
    Beckmann, Matthias W.
    Fasching, Peter A.
    BREAST CANCER RESEARCH, 2025, 27 (01)
  • [2] Multi-Gene Prognostic Signatures and Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in ER-Positive, HER2-Negative Breast Cancer Patients
    Mazo, Claudia
    Barron, Stephen
    Mooney, Catherine
    Gallagher, William M.
    CANCERS, 2020, 12 (05)
  • [3] A predictor model for pathological CR after neoadjuvant chemotherapy in ER-positive/HER2-negative breast cancer
    Fujiki, Yoshitaka
    Yamamoto, Yutaka
    Tomiguchi, Mai
    Sueta, Aiko
    Takeshita, Takashi
    Ibusuki, Mutsuko
    Iwase, Hirotaka
    CANCER SCIENCE, 2018, 109 : 654 - 654
  • [4] Pathological complete response and prognosis after neoadjuvant chemotherapy in patients with HER2-low breast cancer
    Qiao, Weiqiang
    Guo, Wanying
    Liu, Qipeng
    Guo, Xiao
    Deng, Miao
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2023, 64
  • [5] Pathological Complete Response Patients after Neoadjuvant Chemotherapy in Breast Cancer
    Takaoka, Megumi
    Ohsumi, Shozo
    Ikejiri, Haruka
    Shidahara, Tomohiro
    Miyoshi, Yuichiro
    Takahashi, Mina
    Takashima, Seiki
    Aogi, Kenjiro
    ACTA MEDICA OKAYAMA, 2022, 76 (02) : 105 - 111
  • [6] Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer
    von Minckwitz, Gunter
    Eidtmann, Holger
    Rezai, Mahdi
    Fasching, Peter A.
    Tesch, Hans
    Eggemann, Holm
    Schrader, Iris
    Kittel, Kornelia
    Hanusch, Claus
    Kreienberg, Rolf
    Solbach, Christine
    Gerber, Bernd
    Jackisch, Christian
    Kunz, Georg
    Blohmer, Jens-Uwe
    Huober, Jens
    Hauschild, Maik
    Fehm, Tanja
    Mueller, Berit Maria
    Denkert, Carsten
    Loibl, Sibylle
    Nekljudova, Valentina
    Untch, Michael
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (04): : 299 - 309
  • [7] Survival is associated with complete response on MRI after neoadjuvant chemotherapy in ER-positive HER2-negative breast cancer
    Loo, Claudette E.
    Rigter, Lisanne S.
    Pengel, Kenneth E.
    Wesseling, Jelle
    Rodenhuis, Sjoerd
    Peeters, Marie-Jeanne T. F. D. Vrancken
    Sikorska, Karolina
    Gilhuijs, Kenneth G. A.
    BREAST CANCER RESEARCH, 2016, 18
  • [8] Survival is associated with complete response on MRI after neoadjuvant chemotherapy in ER-positive HER2-negative breast cancer
    Claudette E. Loo
    Lisanne S. Rigter
    Kenneth E. Pengel
    Jelle Wesseling
    Sjoerd Rodenhuis
    Marie-Jeanne T. F. D. Vrancken Peeters
    Karolina Sikorska
    Kenneth G. A. Gilhuijs
    Breast Cancer Research, 18
  • [9] Pathological complete response to neoadjuvant chemotherapy and outcomes in Her-2 negative locally advanced breast cancer
    Patel, A. B.
    Sharma, M.
    Joga, S.
    Goel, S.
    Doval, D. C.
    Talwar, V.
    Goyal, S.
    Batra, U.
    ANNALS OF ONCOLOGY, 2023, 34 : S1481 - S1482
  • [10] Predictors of complete pathological response to neoadjuvant chemotherapy in patients with HER2 overexpressing breast cancer
    Boudaouara, O.
    Ben Makhlouf, W.
    Makni, S.
    Mellouli, M.
    Ben Kridis, W.
    Boudawara, T. Sellami
    Chaari, C.
    VIRCHOWS ARCHIV, 2024, 485 : S189 - S190
12345